Разделы презентаций


Lecture 20. Steroid hormones

Secretion by the two inner zones, and to some extend, the outer zone, is controlled by pituitary Corticotropin, which is released in response to the hypothalamic Corticotropin-releasing hormone. Glucocorticoids serve as

Слайды и текст этой презентации

Слайд 1 Lecture 20. Steroid hormones
The adrenal cortex is divided

into three zones that synthesize various steroids from cholesterol and

secrete them.
The outer zona glomerulosa produces mineralocorticoids (for example, Aldosterone) which are responsible for regulated primarily by the renin-angiotensin system.
The middle zona fasciculata synthesizes glucocorticoids (for example, Cortisol) which are concerned with normal metabolism and resistance to stress.
The inner zona reticularis secretes adrenal androgens.
Lecture 20. Steroid hormones    The adrenal cortex is divided into three zones that

Слайд 2



Secretion by the two inner zones, and to some extend,

the outer zone, is controlled by pituitary Corticotropin, which is

released in response to the hypothalamic Corticotropin-releasing hormone. Glucocorticoids serve as feedback inhibitors of Corticotropin and Corticotropin-releasing factor secretion.
Secretion by the two inner zones, and to some extend, the outer zone, is controlled by pituitary

Слайд 3 Mechanism of action
The adrenocorticoids bind to specific

intracellular cytoplasmic receptors in target tissues.
The receptor-hormone

complex then translocates into the nucleus where it acts as a transcrition factor to turn genes on or off, depending on the tissue.
This mechanism requires time to produce an effect. There are other glucocorticoid effects, such as their requirement for catecholamine – mediated dilation of vascular and bronchial musculature or lipolysis, whose effects are immediate.
Mechanism of action    The adrenocorticoids bind to specific intracellular cytoplasmic receptors in target

Слайд 4Glucocorticoids (GCs)
1. Short acting (T1/2

– 36 hrs.): Prednizolon
3. Long acting (T1/2>36 hrs): Triamcinolone, Betamethasone

They

can use as therapeutic agents in a variety of disorders.
Glucocorticoids (GCs)1. Short acting (T1/236 hrs): Triamcinolone, BetamethasoneThey can use as therapeutic agents in a variety of

Слайд 5 The major pharmacodynamic effects of GCs
1. Promote normal intermediary metabolism.
GCs

favor gluconeogenesis by both increasing amino acid uptake by the

liver and kidney and elevating activities of gluconeogenic enzymes.
GCs stimulate protein catabolism (except in the liver) and lipolysis, thereby providing the building blocks and energy needed for glucose synthesis.
The major pharmacodynamic effects of GCs 1. Promote normal intermediary metabolism.GCs favor gluconeogenesis by both increasing

Слайд 6



2. Increase resistance to stress


By raising plasma glucose levels, GCs provide the body with the energy it requires to combat stress caused, for example, by trauma, fright, infection, bleeding, or debilitating disease.
2. Increase resistance to stress

Слайд 7



3. Alter blood cell levels in plasma.


GCs cause a decrease in eosinophils, basophils, monocytes and lymphocytes. In contrast, they increase the blood levels of hemoglobin, erythrocytes, platelets and polymorphonuclear leukocytes (this property is important in the treatment of leukemia).
3. Alter blood cell levels in plasma.

Слайд 8
4. Anti-inflammatory action.
The most important

therapeutic property of the GCs is their ability to dramatically

reduce the inflammatory response and to suppress immunity.
The exact mechanism is complex and incompletely understood.
However, it is know that the lowering and inhibition of peripheral lymphocytes and macrophages play a role.
Also involved is the indirect inhibition of phospholipase A2 (due to the steroid mediated elevation of lipocortin), which blocks the release of arachidonic acid - the precursor of the prostaglandins and leukotrienes, from membrane-bound phospholipid.
4. Anti-inflammatory action.    The most important therapeutic property of the GCs is their

Слайд 9



Affect other components of the endocrine

system.
Feedback inhibition of Corticotropin production by

elevated GCs causes inhibition of further glucocorticoid synthesis as well as thyroid stimulating hormone production, whereas growth hormone production is increased.
Affect other components of the endocrine system.    Feedback inhibition of

Слайд 10

Effects on other systems

These are mostly associated with the adverse effects of

the hormones.
High doses of GCs stimulate gastric acid and pepsin production and may exacerbate ulcers.
Effects on the central nervous system that influence mental status have been identified.
Chronic glucocorticoid therapy can cause severe bone loss. Myopathy leads patients to complain of weakness.

Effects on other systems    These are mostly associated with the

Слайд 11Therapeutic uses of GCs
Replacement therapy for primary adrenocortical insufficiency (Addison’s

disease). This disease is caused by adrenal cortex dysfunction. Hydrocortisone

is given to correct the deficiency.
Replacement therapy for secondary adrenocortical insufficiency. This deficiencies are caused by a defect either in CRF (Corticotropin-releasing factor) production by the hypothalamus or Corticotropin production by the pituitary. Hydrocortisone is also used for these deficiencies.

Therapeutic uses of GCs Replacement therapy for primary adrenocortical insufficiency (Addison’s disease). This disease is caused by

Слайд 12


Diagnosis of Cushing’s syndrome. This syndrome is caused by a

hypersecretion of GCs that is due to either excessive release

of Corticotropin by the anterior pituitary or to an adrenal tumor. The Dexamethasone suppression test is used to diagnose the cause of an individual’s case of Cushing’s syndrome. This synthetic glucocorticoid suppresses Cortisol release in individuals with pituitary-dependent Cushing’s syndrome, but it does not suppress glucocorticoid release from adrenal tumors.
Diagnosis of Cushing’s syndrome. This syndrome is caused by a hypersecretion of GCs that is due to

Слайд 13



Relief of inflammatory symptoms. GCs reduce the manifestation of inflammations

(for example, rheumatoid and osteoarthritic inflammations, inflammatory conditions of the

skin), including the redness, swelling, heat and tenderness that are commonly present at the inflammatory site.
Relief of inflammatory symptoms. GCs reduce the manifestation of inflammations (for example, rheumatoid and osteoarthritic inflammations, inflammatory

Слайд 14


Treatment of allergies. GCs are usefull in the treatment of

the symptoms of drug, serum and transfusion allergic reactions, bronchial

asthma and allergic rhinitis. Betamethasone, Triamcinolone, Prednizolone are the most effective.
Autoimmune diseases.
Organ transplantation.
Limphatic leukemia
Treatment of allergies. GCs are usefull in the treatment of the symptoms of drug, serum and transfusion

Слайд 15Adverse effects of GCs:
osteoporosis
peptic ulceration
glucosuria (hyperglycemia)
increased risk of infection
increased

appetite
hypertension
edema
euphoria
psychoses

Adverse effects of GCs:osteoporosis peptic ulcerationglucosuria (hyperglycemia)increased risk of infectionincreased appetitehypertensionedemaeuphoriapsychoses

Слайд 19Mineralocorticoids
Desoxycorticosterone acetate (DOCA)
Fludrocortisone
Aldosterone
They have only mineralocorticoid activity:

increase renal excretion of Ca++ and K+;
decrease renal excretion

of Na+ and water.
Mineralocorticoids Desoxycorticosterone acetate (DOCA)FludrocortisoneAldosterone  They have only mineralocorticoid activity: increase renal excretion of Ca++ and K+;

Слайд 20



Adverse effects of Mineralocorticoides includes only:
hypokalemia
edema
sodium retention
(without hyperglycaemia, osteoporosis, euphoria).

Adverse effects of Mineralocorticoides includes only:hypokalemiaedemasodium retention(without hyperglycaemia, osteoporosis, euphoria).

Слайд 21 Fludrocortisone
A potent mineralocorticoid having some glucocorticoid activity

as well, orally active, used for:
replacement therapy in Addison’s disease;
congenital

adrenal hyperplasia;
idiopathic postural hypotension.
Fludrocortisone    A potent mineralocorticoid having some glucocorticoid activity as well, orally active, used

Обратная связь

Если не удалось найти и скачать доклад-презентацию, Вы можете заказать его на нашем сайте. Мы постараемся найти нужный Вам материал и отправим по электронной почте. Не стесняйтесь обращаться к нам, если у вас возникли вопросы или пожелания:

Email: Нажмите что бы посмотреть 

Что такое TheSlide.ru?

Это сайт презентации, докладов, проектов в PowerPoint. Здесь удобно  хранить и делиться своими презентациями с другими пользователями.


Для правообладателей

Яндекс.Метрика